Search

everythinglearnresearchcommunity

for

Search:↓

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Juniperus plants contain compounds with potential for developing various medical treatments.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Saw palmetto extract may help treat brain tumors by blocking a specific growth signal and blood vessel formation.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Two distinct caspases in human skin help with cell death and skin formation.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Honokiol helps protect skin from damage and aging caused by cigarette smoke.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Taxifolin from Rhododendron mucronulatum may help prevent hair loss and promote hair growth.

UC.145 may be a new biomarker for predicting gastric cancer.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.